3 months ago
RARE
AnalystsSalveen RichterSalveen Richter's Stock Forecasts
AnalystsSalveen Richter
Analyst Ranking
Top 28%
#1282 out of 4671 analysts
Average Return
+2.41%
Win Rate
41%32 out of 78
Risk vs Reward
Poor
Good
Salveen Richter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | +569.03% | $23.51 | $157.29 | 2020-09-18 - 2021-09-17 | Strong Buy |
Passage Bio IncPASG | +150.07% | $14.02 | $35.06 | 2020-03-24 - 2020-06-25 | Strong Buy |
Denali Therapeutics IncDNLI | +149.21% | $27.98 | $69.73 | 2020-01-27 - 2021-01-27 | Strong Buy |
Moderna IncMRNA | +99.41% | $80.00 | $159.53 | 2020-05-18 - 2021-05-18 | Strong Buy |
Acorda Therapeutics IncACORQ | +89.11% | $1,939.20 | $211.20 | 2018-12-11 - 2019-12-11 | Strong Sell |
Salveen Richter Analyst Color
Get additional color on Salveen Richter's coverage of popular stocks
a year ago
SAGE
2 years ago
ALLO
Salveen Richter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Relay Therapeutics IncRLAY | 2 | Strong Buy | $20.00 | +162.47% | Reinstates | 3 days ago |
Alnylam Pharmaceuticals IncALNY | 5 | Strong Buy | $370.00 | +41.37% | Upgrades | a month ago |
Apellis Pharmaceuticals IncAPLS | 5 | Strong Buy | $74.00 | +101.20% | Maintains | a month ago |
Uniqure NvQURE | 5 | Hold | $10.00 | +80.51% | Maintains | a month ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Strong Buy | $76.00 | +31.42% | Maintains | a month ago |
Moderna IncMRNA | 6 | Strong Buy | $178.00 | +155.45% | Maintains | a month ago |
Ionis Pharmaceuticals IncIONS | 3 | Strong Sell | $37.00 | -9.80% | Maintains | a month ago |
Sage Therapeutics IncSAGE | 6 | Hold | $11.00 | +49.46% | Maintains | 2 months ago |
Agios Pharmaceuticals IncAGIO | 5 | Hold | $53.00 | +17.99% | Maintains | 3 months ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $50.00 | +78.83% | Maintains | 6 months ago |
Intellia Therapeutics IncNTLA | 4 | Hold | $32.00 | +54.81% | Downgrades | 7 months ago |
Adaptive Biotechnologies CorpADPT | 2 | Hold | $5.00 | +16.28% | Maintains | 7 months ago |
Amgen IncAMGN | 3 | Strong Buy | $350.00 | +6.04% | Maintains | 7 months ago |
4d Molecular Therapeutics IncFDMT | 3 | Strong Buy | $81.00 | +409.11% | Reinstates | 7 months ago |
Vertex Pharmaceuticals IncVRTX | 4 | Strong Buy | $559.00 | +16.79% | Maintains | 7 months ago |
Incyte CorpINCY | 4 | Hold | $65.00 | +2.59% | Maintains | 10 months ago |
2seventy Bio IncTSVT | 4 | Hold | $5.00 | +8.93% | Downgrades | a year ago |
Centessa Pharmaceuticals PLCCNTA | 4 | Hold | $5.00 | N/A | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 3 | Strong Buy | $215.00 | N/A | Maintains | a year ago |
Amicus Therapeutics IncFOLD | 1 | Hold | $11.00 | N/A | Maintains | 2 years ago |
Allogene Therapeutics IncALLO | 4 | Strong Buy | $31.00 | N/A | Maintains | 2 years ago |
Autodesk IncADSK | 1 | Strong Buy | $225.00 | N/A | Maintains | 2 years ago |
Prime Medicine IncPRME | 1 | Hold | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Lyell Immunopharma IncLYEL | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Precision Biosciences IncDTIL | 5 | Hold | $30.00 | N/A | Maintains | 2 years ago |
Kronos Bio IncKRON | 2 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Recursion Pharmaceuticals IncRXRX | 3 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Taysha Gene Therapies IncTSHA | 2 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Acadia Pharmaceuticals IncACAD | 6 | Strong Sell | $12.00 | N/A | Downgrades | 2 years ago |
Sana Biotechnology IncSANA | 2 | Hold | $6.00 | N/A | Maintains | 2 years ago |
Bread Financial Holdings IncBFH | 1 | Hold | $43.00 | N/A | Maintains | 2 years ago |
Biogen IncBIIB | 2 | Strong Buy | $370.00 | N/A | Upgrades | 2 years ago |
Regeneron Pharmaceuticals IncREGN | 2 | Strong Buy | $970.00 | N/A | Maintains | 2 years ago |
Bluebird Bio IncBLUE | 3 | Strong Sell | $3.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 2 | Hold | $46.00 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 1 | Strong Sell | $100.00 | N/A | Maintains | 2 years ago |
Arcus Biosciences IncRCUS | 2 | Hold | $28.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $39.00 | N/A | Downgrades | 3 years ago |
Gilead Sciences IncGILD | 2 | Hold | $80.00 | N/A | Initiates Coverage On | 3 years ago |
Omega Therapeutics IncOMGA | 1 | Hold | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Sell | $10.00 | N/A | Downgrades | 3 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Passage Bio IncPASG | 3 | Strong Buy | $30.00 | N/A | Upgrades | 4 years ago |
Mirati Therapeutics IncMRTX | 1 | Strong Buy | $151.00 | N/A | Initiates Coverage On | 4 years ago |
Paccar IncPCAR | 3 | Hold | $50.00 | N/A | Maintains | 4 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Hold | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Cellectis SaCLLS | 1 | Strong Sell | $11.00 | N/A | Downgrades | 5 years ago |
Seagen IncSGEN | 1 | Strong Buy | $165.00 | N/A | Maintains | 5 years ago |
Acorda Therapeutics IncACORQ | 4 | Strong Sell | $1,200.00 | N/A | Downgrades | 6 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Spark Therapeutics IncONCE | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.